Former Pfizer CEO, CFO say they will not be involved in Starboard's campaign against drugmaker
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, which reportedly wants the U.S. drug giant to make changes to turn its performance around.
Former Pfizer executives pull out of activist investor Starboard’s campaign
The reversal marks a twist in an unusual corporate clash. While activists occasionally team up with major shareholders, such as when Nelson Peltz joined former Marvel executive Isaac Perlmutter in a campaign for change at Disney, it is rare for longtime company executives to support hostile shareholders.
Starboard Value reportedly has taken a roughly $1 billion stake in Pfizer, as the activist investor seeks to turn the ...
Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of ...
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
Pfizer's stock has struggled due to declining demand for COVID-19 treatments, but activist investor Starboard's $1 billion ...
Pfizer ( PFE 3.18%) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback